Receptos Announces Proposed Underwritten Public Offering Of Common Stock
November 17, 2014 at 16:02 PM EST
Receptos, Inc. (Nasdaq: RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic ...